Market Place
Sourcing Support
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the
US Food and Drug Administration (FDA) was reeling under the impact of the
pandem
Company Tracker: Pfizer turns to acquisitions as Covid products’ sales nosedive
Over the last five years, a
lot has changed for Pfizer Inc, one of the world’s leading pharma
